How do gefitinib and afatinib compare with other cytotoxic chemotherapy regimens for treatment of people with advanced epidermal growth factor receptor mutation non-small-cell lung cancer?
2017 ◽
Vol Volume 10
◽
pp. 1757-1766
◽
2018 ◽
Vol 56
(2)
◽
pp. 179-183
◽
2006 ◽
Vol 1
(4)
◽
pp. 367-376
◽